niceph 11

niceph 11

Comino’s High-Performance Server: A Game-Changer for AI and HPC Workloads In an exciting advancement for tech enthusiasts, Comino has rolled out its latest innovation, the Grando H100 Server. Designed to cater to demanding AI and high-performance computing (HPC) needs, this powerhouse integrates cutting-edge technology to deliver exceptional results. At the heart of the Grando H100 is AMD’s Threadripper PRO 7995WX processor, equipped with a staggering 96 cores and 192 threads. Utilizing AMD’s Zen 4 architecture, it supports a remarkable 2TB of DDR5 memory, making it ideal for handling extensive data processing tasks with ease. Enhancing its capabilities further, the server is outfitted with two Nvidia H100 NVL GPUs, together offering an impressive 188GB of GPU memory. The backbone of this system is its ASUS SAGE WRX90 motherboard, which supplies plentiful PCIe Gen5 lanes, ensuring seamless connections for GPUs and high-speed storage. Comino, famed for its expertise in liquid-cooled systems, has incorporated an advanced cooling solution within the Grando H100. This setup promises stable performance under heavy loads while operating quietly. In recent benchmarks, the Grando H100 showcased excellent performance in AI-specific computations, rendering, and compression tasks. However, in certain traditional rendering scenarios, it did not outperform systems optimized with alternative GPUs. Summing up these features, the Grando H100 Server stands out as an essential tool for enterprises and professionals concentrating on AI-centric workloads. With its robust build and innovative cooling, it provides both flexibility and reliability in demanding environments, leaving tech enthusiasts eager for what’s next. The Future of AI and HPC: Why Comino’s Grando H100 Server is the Ultimate Powerhouse Introduction Comino’s latest offering, the Grando H100 Server, redefines the standards for AI and high-performance computing (HPC) workloads. This robust server is packed with cutting-edge technology and promises to be a game-changer for tech enthusiasts and enterprises focusing on AI-driven initiatives. Features and Specifications – Unparalleled Processing Power : At the core of the Grando H100 is AMD’s Threadripper PRO 7995WX processor, boasting 96 cores and 192 threads. This processor utilizes AMD’s Zen 4 architecture, making it a potent force for AI and data processing tasks. – Massive Memory Capacity : With support for up to 2TB of DDR5 memory, the Grando H100 can handle vast datasets with ease. This feature is particularly beneficial for AI applications that require extensive memory for efficient processing. – Advanced GPU Integration : The server includes dual Nvidia H100 NVL GPUs, which contribute a total of 188GB of GPU memory. This configuration enhances AI-specific computations, rendering, and compression tasks. – Innovative Cooling System : Comino’s reputation for liquid cooling excellence is demonstrated in the Grando H100. The advanced cooling technology ensures stable and quiet operation, even under the heaviest workloads. Use Cases The Grando H100 is tailored for enterprises focused on AI-centric workloads. It is ideal for: – AI Model Training and Inference : The server’s expansive GPU memory and processing power enable rapid AI model training and accurate inference, making it suitable for research and development environments. – Data-Intensive Simulations : Industries such as finance and healthcare, which rely on complex simulations and real-time data analysis, will find the Grando H100’s capabilities indispensable. – Rendering and Media Workflows : While the server excels in AI-specific rendering tasks, it may not match some specialized systems for traditional rendering. However, it remains a formidable choice for media professionals requiring high performance. Pros and Cons – Pros : Exceptional computing power, advanced cooling, expansive memory and GPU capabilities. – Cons : May not outperform alternative GPU-optimized systems in specific traditional rendering scenarios. Market Analysis and Trends With the surge of AI applications and the growing demand for high-performance computing, the market for servers like the Grando H100 is expanding. Enterprises are increasingly seeking reliable and powerful solutions to manage massive datasets efficiently. Comino’s Grando H100 sets a precedent in this evolving market, aligning with the trend towards more specialized hardware for AI and HPC environments. Conclusion The Comino Grando H100 Server stands out as a necessary asset for businesses leveraging AI technologies. Its robust build, coupled with industry-leading components, positions it as a leader in the realm of high-performance computing. This server promises to pave the way for future innovations, meeting the market’s demand for a balance of power, efficiency, and reliability. For more information about their latest innovations, visit Comino .

Loews Corp. stock rises Friday, still underperforms market

S.Sudan's Kiir holds urgent talks over shootout at ex-spy chief's homeInside the Gaetz ethics report, a trove of new details alleging payments for sex and drug use

Jury awards $310 million to parents of teen killed in fall from Orlando amusement park ride ORLANDO, Fla. (AP) — The parents of a 14-year-old Missouri boy who fell to his death from a Florida amusement park ride has won a $310 million verdict against the attraction's Austrian builder. The Orlando jury on Thursday ordered Funtime to pay Tyre Sampson's parents $155 million each. The trial lasted only a day as Funtime never appeared in court to defend itself. Icon Park had already settled with Sampson’s family for an undisclosed amount. Sampson stood 6 foot, 2 inches tall and weighed 380 pounds. He fell from the Orlando Free Fall ride at Icon Park because the harness did not fit him and he wasn't warned. Princess of Wales takes another step in return to public life after chemotherapy with carol service LONDON (AP) — The Princess of Wales is taking another step in her return to public life following cancer treatment as she hosts her annual Christmas carol service at Westminster Abbey. This year’s concert is designed to celebrate the support people give to one another, especially as they struggle through difficult times, a theme that may have particular resonance for the princess after abdominal surgery and chemotherapy forced her to step back from public duties for much of 2024. The princess, often referred to simply as Kate, alluded to this in a letter thanking the 1,600 people invited to attend the event because of their efforts to help others in their communities. Hall of Famer Randy Moss is stepping away from ESPN for an extended time to deal with health issue Hall of Fame wide receiver Randy Moss is stepping away from his ESPN analyst role for an extended time to focus on a personal health challenge, the network said in a statement. Moss revealed last week that he’s dealing with a health issue and asked fans to pray for him and his family. The 47-year-old ESPN football analyst made his announcement on Instagram from the set of the network’s “Sunday NFL Countdown” show. He directed his message to men and urged them to get checkups and bloodwork done, without specifying any particular illness. More than a million oven gloves are being recalled after consumers report 92 minor burns NEW YORK (AP) — More than one million pairs of oven gloves are being recalled due to a burn hazard, after dozens of injury reports. Video and e-commerce retailer QVC is recalling about 1.1 million of its “Temp-tations Oven Gloves” because they fail to provide sufficient heat protection. According to the U.S. Consumer Product Safety Commission, QVC has received 162 reports of insufficient heat protection, including 92 minor burns. Consumers in possession of the now-recalled gloves are urged to stop using them immediately — and contact QVC for a refund. Lionel Messi wins MLS MVP award, the latest trophy on a long list of honors for the Inter Miami star FORT LAUDERDALE, Fla. (AP) — Lionel Messi is the MVP of Major League Soccer for 2024. The award comes after a season where he missed 15 of Inter Miami’s 34 regular-season matches with injuries or commitments to Argentina’s national team. He still factored into a league-high 36 goals by scoring 20 and assisting on 16 others. His 2.1 goal contributions per 90 minutes played is the best by any player in any season in MLS history. MLS revealed the voting results Friday. Messi edged out Columbus Crew forward Cucho Hernández for the award, which is determined by a poll of players, club technical staff and select media members. Alternative healer gets 10 years in UK prison for death of woman at slap therapy workshop LONDON (AP) — An alternative healer who advocated “slapping therapy” to treat a range of maladies has been sentenced to 10 years in prison for the death of a 71-year-old diabetic woman who stopped taking insulin during his workshop. Hongchi Xiao, 61, was sentenced Friday after being convicted of manslaughter by gross negligence for failing to get medical help for Danielle Carr-Gomm in 2016. Prosecutors say she was howling in pain and frothing at the mouth during the fourth day of a workshop. The California healer promoted paida lajin therapy that advocates slapping to release “poisonous waste” from the body. He was previously convicted of manslaughter in the death of a six-year-old boy in Australia. Stellantis recalling more than 300,000 Ram trucks for braking system defect Stellantis is recalling more than 300,000 Ram Heavy Duty pickup trucks because a faulty part could cause certain braking and tracking systems to fail. The Netherlands-based automaker said the hydraulic control unit on the trucks is prone to failure, which can cause the anti-lock brake, electronic stability control and traction control systems to not work properly. Stellantis said regular braking systems are not affected by the defective part and that it’s unaware of any related injuries. The trucks in question are all model years 2017-18 and include the Ram 2500, 3500, 4500 and 5500. The company is unaware of any injuries related to the defect. El Salvador's president is triumphant after his bet on bitcoin comes true SAN SALVADOR, El Salvador (AP) — El Salvador's President Nayib Bukele is triumphant about his big bet on bitcoin as the cryptocurrency reached historic highs, surpassing $100,000 for the first time. Bitcoin has been legal tender in the country since 2021 but it never quite matched the president’s enthusiasm. The value of the government’s reported investment now stands at more than $600 million. Bitcoin has rallied mightily since Donald Trump’s election victory last month, exceeding the $100,000 mark on Wednesday night, just hours after the president-elect said he intends to nominate cryptocurrency advocate Paul Atkins to be the next chair of the Securities and Exchange Commission. NBA returning to China for pair of Suns-Nets preseason games in 2025 The NBA is returning to China next season. The league has struck a deal to play preseason games there more than five years after the league was effectively banned for Commissioner Adam Silver not punishing Daryl Morey for tweeting support of anti-government protesters in Hong Kong. Brooklyn and Phoenix will play games in China’s gambling hub of Macao on Oct. 10, 2025, and again two days later. There are more games planned for China in 2026, a source told The Associated Press. F1 champion Max Verstappen to become first-time father with girlfriend Kelly Piquet ABU DHABI, United Arab Emirates (AP) — Formula 1 champion Max Verstappen is set to become a father for the first time with his girlfriend Kelly Piquet. There’s racing heritage on both sides of the family. Verstappen secured his fourth F1 title last month and Kelly’s father Nelson Piquet was a three-time champion in the 1980s. Verstappen says on Instagram that "we couldn’t be happier with our little miracle.” Verstappen is aiming to win his 10th F1 race of the year at the season-ending Abu Dhabi Grand Prix on Sunday. Practice gets underway later.Christopher Nolan is following his Oscar-winning “Oppenheimer” with a true epic: Homer’s “The Odyssey.” It will open in theaters on July 17, 2026, Universal Pictures said Monday. Details remain scarce, but the studio teased that it will be a “mythic action epic shot across the world using brand new IMAX technology.” It will also be the first time that an adaptation of Homer’s saga will play on IMAX film screens. Recommended Videos Nolan has been an IMAX enthusiast for years, going back to “The Dark Knight,” and has made his last three films exclusively using large format film and the highest resolution film cameras. For “Oppenheimer,” the first black-and-white IMAX film stock was developed. Nolan hasn’t said specifically what the new technology for “The Odyssey” will be, but earlier this month he told The Associated Press that they’re in an intensive testing phase with IMAX to prepare for the new production. “They have an incredible engineering staff, really brilliant minds doing extraordinary work,” Nolan said. “It’s wonderful to see innovation in the celluloid film arena still happening and happening at the highest level possible.” “The Odyssey” will be Nolan’s second collaboration with Universal Pictures following “Oppenheimer,” which earned nearly $1 billion at the box office and won the filmmaker his first Oscars, including for best director and best picture . Rumors about his next project have been swirling ever since, with near-daily speculations about plot — none of which turned out to be true — and casting. While there are many reports about actors joining the ensemble, none has been officially confirmed by the studio.

Building a state-of-the-art criminal justice center with just three guys

UnitedHealth shooting dredges up enmity for health insurersMahomes threw two touchdown passes to Noah Gray for the second straight week as the Kansas City Chiefs held off the Carolina Panthers 30-27 on Sunday. A week after losing at Buffalo, the two-time defending Super Bowl champion Chiefs (10-1) maintained their position atop the AFC. Mahomes completed a 35-yard touchdown strike to Gray on the game’s opening possession and found him again for an 11-yard TD in the second quarter. Gray has four touchdown catches in the last two weeks — twice as many as nine-time Pro Bowler Travis Kelce has all season — and has become a weapon in the passing game for the Chiefs, who lost top wide receiver Rashee Rice to a season-ending knee injury in Week 4. Kelce was still a factor Sunday with a team-high six catches for 62 yards, although the four-time All-Pro looked dejected after dropping one easy pass. Kelce has 62 receptions for 507 yards this season, while Gray has 26 catches for 249 yards. But Gray's development is a good sign for the Chiefs — and he's on the same page with Mahomes. On his second TD, Gray said Mahomes “gave me the answer to the test there” before the play. “He told me what coverage it was pre-snap," said Gray, who had four receptions for 66 yards. “That’s just the blessing you have of playing with a quarterback like that. Offensive line did a great job blocking that up and the receivers did a great job running their routes to pop me open. Really just a group effort right there on that touchdown.” Gray said that's nothing new. “Pat’s preparation, his leadership is just something that I’m fortunate enough to play alongside,” Gray said. "I love it. It gets me motivated every time we go out there for a long drive. Having a leader like that, that prepares every single week in-and out, knows defenses, knows the game plans. “I’m just fortunate enough to play alongside a guy like that.” Mahomes completed 27 of 37 passes for 269 yards and three TDs, and he knew what to do on the second TD to Gray. “It's not just me, it's the quarterback coaches and the players, we go through certain checks you get to versus certain coverages,” Mahomes said. “I was able to see by the way they lined up they were getting into their cover-zero look. I alerted the guys to make sure they saw what I saw and I gave the check at the line of scrimmage.” AP NFL: https://apnews.com/hub/nfl

Civic Coalition's Critical Primary Showdown: Trzaskowski vs SikorskiTrue freshman Luke Kromenhoek threw three touchdown passes and Caziah Holmes ran for two more as host Florida State routed Charleston Southern 41-7 on Saturday afternoon in Tallahassee, Fla. The Seminoles (2-9) convincingly snapped a six-game losing streak and ensured that the Buccaneers (1-11) would finish theirs on a 10-game skid. Florida State has not had much to celebrate during one of its worst seasons in program history. But on Saturday, the Seminoles overcame a rough start and put together one of their more complete efforts of the season. Florida State had not scored more than 21 points in a game prior to Saturday's contest and its 175 rushing yards more than doubled its average (80.5 per game) this season. No single runner had over 40 yards, but seven rushers combined for that output on 34 attempts. The Seminoles entered the game ranked 130th out of 133 FBS teams in rushing offense. Holmes, a senior, finished with three carries for 38 yards, including touchdown runs of 3 and 18 yards. Kromenhoek gave Florida State a sliver of hope for its quarterback future as he completed 13 of 20 passes for 209 yards and no interceptions. He threw TD passes for Amaree Williams, Ja'Khi Douglas and Hykeem Williams. The highlight was a 71-yard touchdown pass to Douglas on the first play from scrimmage of the second half to put the Seminoles ahead 24-0. Douglas finished with 82 yards receiving on three catches, and 10 different Florida State players caught passes for 240 total yards. The Seminoles went 6 of 10 on third downs after averaging only a 25 percent conversion rate all season. Their defense held Charleston Southern to 275 total yards (57 rushing) and forced two turnovers. Florida State was unable to hang on to the shutout, however, as Bucs quarterback Kaleb Jackson found Landon Sauers for a 7-yard touchdown pass with 57 seconds left in the fourth quarter. Jackson completed 22 of 32 passes for 218 yards, one touchdown and one interception. The Bucs defense recorded three sacks led by Davion Williams, who had eight tackles, 2.5 tackles for loss and one sack. The Seminoles will conclude their season next Saturday at home against rival Florida. --Field Level MediaUS stock market is entering Christmas, New Years holiday period with New York Stock Exchange and Nasdaq closing early on Christmas eve on December 24. ET Year-end Special Reads Top 10 equity mutual funds of the year. Do you have any? How India flexed its global power muscles in 2024 2024 was the year India became the talk of America On Christmas Eve, both the Nasdaq and the New York Stock Exchange will close early, with trading halting at 1 pm (ET). Similarly, the US bond market is scheduled for an early closure, with operations ending at 2 pm (ET). These adjustments in market hours reflect the holiday schedule for December 24, allowing traders and investors to celebrate the season with shortened trading sessions, USA Today reported. On Christmas Day on December 25, US stock market main indexes S&P 500, Dow Jones Industrial Average, and Nasdaq will remain closed, as per a report on USA Today. US stock market indexes will function for normal hours on Boxing Day, 2024 on December 26. Wall Street's main indexes were on track for a subdued open in a shortened trading session on Tuesday as U.S. equity markets enter a historically strong period before rounding off their second consecutive year of gains. With few major catalysts, thin trading volumes expected in the final days of the year raise the prospect of choppy trading. Stock markets will shut at 1:00 pm (ET) on Tuesday and will be closed for Christmas on Wednesday. At 08:32 am (ET), Dow E-minis were down 22 points, or 0.05 per cent, S&P 500 E-minis were up 8 points, or 0.13 per cent, and Nasdaq 100 E-minis were up 53.25 points, or 0.24 per cent. Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Data Science MySQL for Beginners: Learn Data Science and Analytics Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Strategy ESG and Business Sustainability Strategy By - Vipul Arora, Partner, ESG & Climate Solutions at Sattva Consulting Author I Speaker I Thought Leader View Program Marketing Modern Marketing Masterclass by Seth Godin By - Seth Godin, Former dot com Business Executive and Best Selling Author View Program Artificial Intelligence(AI) Tabnine AI Masterclass: Optimize Your Coding Efficiency By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Office Productivity Zero to Hero in Microsoft Excel: Complete Excel guide 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Mastering Full Stack Development: From Frontend to Backend Excellence By - Metla Sudha Sekhar, IT Specialist and Developer View Program Data Analysis Animated Visualizations with Flourish Studio: Beginner to Pro By - Prince Patni, Software Developer (BI, Data Science) View Program Artificial Intelligence(AI) Generative AI for Dynamic Java Web Applications with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Basics of Generative AI: Unveiling Tomorrows Innovations By - Metla Sudha Sekhar, IT Specialist and Developer View Program Entrepreneurship Boosting Startup Revenue with 6 AI-Powered Sales Automation Techniques By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Artificial Intelligence(AI) Learn InVideo AI: Create Videos from Text Easily By - Prince Patni, Software Developer (BI, Data Science) View Program Office Productivity Excel Essentials to Expert: Your Complete Guide By - Study At Home, Quality Education Anytime, Anywhere View Program Marketing Performance Marketing for eCommerce Brands By - Zafer Mukeri, Founder- Inara Marketers View Program Web Development Master RESTful APIs with Python and Django REST Framework: Web API Development By - Metla Sudha Sekhar, IT Specialist and Developer View Program Strategy Succession Planning Masterclass By - Nigel Penny, Global Strategy Advisor: NSP Strategy Facilitation Ltd. View Program Data Analysis Learn Power BI with Microsoft Fabric: Complete Course By - Prince Patni, Software Developer (BI, Data Science) View Program Artificial Intelligence(AI) AI for Everyone: Understanding and Applying the Basics on Artificial Intelligence By - Ritesh Vajariya, Generative AI Expert View Program Entrepreneurship Building Your Winning Startup Team: Key Strategies for Success By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Artificial Intelligence(AI) Mastering C++ Fundamentals with Generative AI: A Hands-On By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Intermediate Java Mastery: Method, Collections, and Beyond By - Metla Sudha Sekhar, IT Specialist and Developer View Program Astrology Vastu Shastra Course By - Sachenkumar Rai, Vastu Shashtri View Program The S&P 500 and the Nasdaq notched two consecutive sessions of gains on Monday, helped by advances in a handful of megacap and growth companies. FAQs Q1. What are main indexes of US Stock Market? A1. Main indexes of US Stock Market are S&P 500, Dow Jones Industrial Average, and Nasdaq. Q2. Is US Stock Market closing on Christmas day? A2. Yes, US Stock Market is closing on Christmas day. (You can now subscribe to our Economic Times WhatsApp channel )

Qualcomm Investor Day Highlights Success Via Increased DiversificationA Tennessee man is convicted of killing 2 at a high school basketball game in 2021

A number of former I’m A Celebrity... Get Me Out of Here contestants have confirmed they are backing an Irish contestant to win the 24th series of the ITV show. The Ant and Dec presented celebrity reality show returned last week with podcaster and influencer GK Barry, singer Tulisa and Irish boxing promoter Barry McGuigan among the campmates. In further delight for Irish viewers, former Love Island star turned TV presenter Maura Higgins entered as a late arrival alongside Reverend Richard Coles. The duo hit up the junkyard , where they were tasked with conning their fellow campmates into thinking they were living in squalor — rather than luxury. With the show being back just one week, people are already picking their winners with many social media users backing Maura to take the throne as Queen of the Jungle. Former I’m A Celeb contestants Phil Tufnell and Dean Gaffney have their money on former professional boxer Barry. Cricket star Phil won the TV show in 2003, and backed his fellow sports star in following suit. Speaking to Betway, he said: ‘Barry McGuigan would be great to win, I’ve also met Danny [Jones] and he’s a great guy.’ Soap star Dean branded McGuigan a ‘dark horse,’ but crowned Coleen Rooney as his winner, when speaking to Heart Bingo. Elsewhere, fellow boxer turned contestant Amir Khan backed McGuigan who he branded as ‘brilliant.’ Speaking to Prime Casino , Amir said Barry was a ‘very charming guy.’ ‘He’s got the characteristics to go in there and win it, definitely,’ Amir added. During the week, Barry got emotional as he spoke about his late daughter , Danika, who died at the age of 33 years old. Danika had battled colon cancer, with Barry tearing up as he remembered his daughter with his campmates. Nika had been ill throughout her childhood, and had leukaemia by the time she was 11, something McGuigan described as ‘very tough.’ He broke down in tears , unable to get his words out, as his jungle mates gathered to embrace him and offer words of encouragement. N-Dubz singer Tulisa consoled him, saying: ‘You’re a man feeling pain and you’re vulnerable about it – that takes strength.’COLUMBIA, Mo. — After giving up a score with just over three minutes left to play, Alex Wilkerson put the Lamar Tigers on his back, sore body and all, and drove them 72 yards in 2:20 of game clock to win the second Class 2 state title in as many years. The Tigers defeated Fair Grove 28-25. Wilkerson completed passes of 15, 16 and nine yards while running for 16 yards to convert a 3rd and 9 with less than a minute to go. Three plays later, he punched it in from five yards out to put his team up. His 16-yard completion to Trent Torbeck pushed the ball to the 34 and and converted a 3rd and 10 to avoid a fourth down. In opposite fashion of typical Lamar football, the Tigers threw the ball eight times in 12 plays on the final drive. Lamar overcomes a 5-4 regular season to claim its 10th state championship in program history. Fair Grove was 14-0 going into Friday's game.

Workplace solutions company has filed its draft red herring prospectus (DRHP) with markets regulator SEBI to raise funds through an initial public offering (IPO). The company’s IPO consists of a fresh issue of equity shares of up to Rs 750 crore and an offer for sale of equity shares of up to Rs 100 crore by the promoter-selling shareholders, Rishi Das and Meghna Agarwal. IndiQube intends to use Rs 462.6 crore of the raised proceeds towards funding capital expenditures related to establishing new centres and Rs 100 crore towards the repayment of certain borrowings availed by the company. Founded in 2015, the company currently manages around 103 centres across 13 cities and has a clientele roster ranging from Indian corporates as well as startups such as NoBroker, Redbus, upGrad. The company reported a total income of Rs 867.6 crore in FY24 compared to Rs 601.2 crore in FY23. Interestingly, for the three months ended June 30, 2024, the company derived 91.59% of its revenue from operations from centers in Bengaluru, Pune, and Chennai collectively. This trend was observed in FY24, FY23, and FY22. IndiQube has become the latest company to file for an IPO after several startups such as EV-maker and food delivery platform went public in 2024. Several companies including Ather Energy and omnichannel jewellery brand Bluestone has also filed draft papers to go public. The company’s DRHP also comes at a time when flexible workspaces are becoming a rising trend in the commercial office market as hybrid working models become more common. The Book Running Lead Managers to the offer are ICICI Securities Limited and JM Financial Limited and the equity shares are proposed to be listed on BSE and NSE. Edited by Affirunisa KankudtiJennison Associates LLC lifted its stake in shares of Perdoceo Education Co. ( NASDAQ:PRDO – Free Report ) by 23.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,170 shares of the company’s stock after acquiring an additional 10,231 shares during the quarter. Jennison Associates LLC owned 0.08% of Perdoceo Education worth $1,183,000 at the end of the most recent reporting period. A number of other hedge funds have also modified their holdings of PRDO. Vanguard Group Inc. increased its stake in Perdoceo Education by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 5,896,257 shares of the company’s stock worth $103,538,000 after purchasing an additional 45,259 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Perdoceo Education by 0.6% during the second quarter. Dimensional Fund Advisors LP now owns 5,069,173 shares of the company’s stock valued at $108,580,000 after acquiring an additional 28,909 shares during the period. Renaissance Technologies LLC lifted its position in shares of Perdoceo Education by 2.5% in the 2nd quarter. Renaissance Technologies LLC now owns 4,505,687 shares of the company’s stock valued at $96,512,000 after acquiring an additional 107,918 shares in the last quarter. Pacer Advisors Inc. boosted its stake in Perdoceo Education by 24.3% in the 2nd quarter. Pacer Advisors Inc. now owns 2,650,123 shares of the company’s stock worth $56,766,000 after purchasing an additional 518,048 shares during the period. Finally, LSV Asset Management grew its position in Perdoceo Education by 3.9% during the 2nd quarter. LSV Asset Management now owns 2,010,254 shares of the company’s stock worth $43,060,000 after purchasing an additional 75,293 shares in the last quarter. 93.46% of the stock is currently owned by institutional investors and hedge funds. Perdoceo Education Stock Performance Perdoceo Education stock opened at $27.33 on Friday. Perdoceo Education Co. has a twelve month low of $16.12 and a twelve month high of $29.47. The firm has a market cap of $1.80 billion, a PE ratio of 13.73, a P/E/G ratio of 0.79 and a beta of 1.04. The firm’s 50 day moving average price is $22.79 and its two-hundred day moving average price is $22.57. Perdoceo Education Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, December 2nd will be issued a $0.13 dividend. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $0.52 dividend on an annualized basis and a yield of 1.90%. Perdoceo Education’s dividend payout ratio is currently 26.13%. Insider Activity at Perdoceo Education In other Perdoceo Education news, insider Michele A. Peppers sold 6,476 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $21.00, for a total transaction of $135,996.00. Following the transaction, the insider now directly owns 61,952 shares of the company’s stock, valued at $1,300,992. This represents a 9.46 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website . Also, Director Patrick W. Gross sold 3,400 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $26.74, for a total value of $90,916.00. Following the completion of the sale, the director now directly owns 69,635 shares of the company’s stock, valued at $1,862,039.90. This represents a 4.66 % decrease in their position. The disclosure for this sale can be found here . Over the last quarter, insiders have sold 40,450 shares of company stock valued at $1,036,206. 1.81% of the stock is currently owned by corporate insiders. Analysts Set New Price Targets A number of research firms have recently issued reports on PRDO. StockNews.com lowered Perdoceo Education from a “strong-buy” rating to a “buy” rating in a report on Friday. Barrington Research increased their price objective on Perdoceo Education from $30.00 to $32.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Get Our Latest Analysis on Perdoceo Education About Perdoceo Education ( Free Report ) Perdoceo Education Corporation provides postsecondary education through online, campus-based, and blended learning programs in the United States. It operates in two segments, Colorado Technical University and The American InterContinental University System. The Colorado Technical University segment offers academic programs, such as business and management, nursing, healthcare management, computer science, engineering, information systems and technology, project management, cybersecurity, and criminal justice. See Also Want to see what other hedge funds are holding PRDO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perdoceo Education Co. ( NASDAQ:PRDO – Free Report ). Receive News & Ratings for Perdoceo Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perdoceo Education and related companies with MarketBeat.com's FREE daily email newsletter .

Today’s NYT Mini Crossword Clues And Answers For Monday, December 30thUK wants to hire EU negotiator to 'reset' relationsCiting text messages, travel receipts, online payments and testimony, the bipartisan committee paints a picture of a lifestyle in which Gaetz and others connected with younger women for drug-fueled parties, events or trips, with the expectation the women would be paid for their participation. The former congressman, who filed a last-minute lawsuit to try to block the report's release Monday, slammed the committee's findings. Gaetz has denied any wrongdoing and has insisted he never had sex with a minor. And a Justice Department investigation into the allegations ended without any criminal charges filed against him. "Giving funds to someone you are dating — that they didn't ask for — and that isn't 'charged' for sex is now prostitution?!?" Gaetz wrote in one post Monday. "There is a reason they did this to me in a Christmas Eve-Eve report and not in a courtroom of any kind where I could present evidence and challenge witnesses." Here's a look at some of the committee's key findings: 'Sex-for-money arrangements,' drug-fueled parties and trips The committee found that between 2017 and 2020, Gaetz paid tens of thousands of dollars to women "likely in connection with sexual activity and/or drug use." He paid the women using through online services such as PayPal, Venmo and CashApp and with cash or check, the committee said. The committee said it found evidence that Gaetz understood the "transactional nature" of his relationships with the women. The report points to one text exchange in which Gaetz balked at a woman's request that he send her money, "claiming she only gave him a 'drive by.'" Women interviewed by the committee said there was a "general expectation of sex," the report said. One woman who received more than $5,000 from Gaetz between 2018 and 2019 said that "99 percent of the time" that when she hung out with Gaetz "there was sex involved." However, Gaetz was in a long-term relationship with one of the women he paid, so "some of the payments may have been of a legitimate nature," the committee said. Text messages obtained by the committee also show that Gaetz would ask the women to bring drugs to their "rendezvous," the report said. While most of his encounters with the women were in Florida, the committee said Gaetz also traveled "on several occasions" with women whom he paid for sex. The report includes text message exchanges in which Gaetz appears to be inviting various women to events, getaways or parties, and arranging airplane travel and lodging. Gaetz associate Joel Greenberg, who pleaded guilty to sex trafficking charges in 2021, initially connected with women through an online service. In one text with a 20-year-old woman, Greenberg suggested if she had a friend, the four of them could meet up. The woman responded that she usually does "$400 per meet." Greenberg replied: "He understands the deal," along with a smiley face emoji. Greenberg asked if they were old enough to drink alcohol, and sent the woman a picture of Gaetz. The woman responded that her friend found him "really cute." "Well, he's down here for only for the day, we work hard and play hard," Greenberg replied. 'Substantial evidence' indicates that Gaetz had sex with an underage girl, the committee said The report details a party in July 2017 in which Gaetz is accused of having sex with "multiple women, including the 17-year-old, for which they were paid." The committee pointed to "credible testimony" from the now-woman herself as well as "multiple individuals" who corroborated the allegation. The then-17-year-old — who had just completed her junior year in high school — told the committee that Gaetz paid her $400 in cash that night, "which she understood to be payment for sex," according to the report. The woman acknowledged that she had taken ecstasy the night of the party, but told the committee that she was "certain" of her sexual encounters with the then-congressman. There's no evidence that Gaetz knew she was a minor when he had sex with her, the committee said. The woman told the committee she didn't tell Gaetz she was under 18 at the time and he didn't ask how old she was. Rather, the committee said Gaetz learned she was a minor more than a month after the party. But he stayed in touch with her after that and met up with her for "commercial sex" again less than six months after she turned 18, according to the committee. Gaetz said evidence would 'exonerate' him but provided none of it In sum, the committee said it authorized 29 subpoenas for documents and testimony, reviewed nearly 14,000 documents and contacted more than two dozen witnesses. But when the committee subpoenaed Gaetz for his testimony, he failed to comply. "Gaetz pointed to evidence that would 'exonerate' him yet failed to produce any such materials," the committee said. Gaetz "continuously sought to deflect, deter, or mislead the Committee in order to prevent his actions from being exposed." The report details a months-long process that dragged into a year as it sought information from Gaetz that he decried as "nosey" and a "weaponization" of government against him. In one notable exchange, investigators were seeking information about the expenses for a 2018 getaway with multiple women to the Bahamas. Gaetz ultimately offered up his plane ticket receipt "to" the destination, but declined to share his return "from" the Bahamas. The report said his return on a private plane and other expenses paid by an associate were in violation of House gift rules. In another Gaetz told the committee he would "welcome" the opportunity to respond to written questions. Yet, after it sent a list of 16 questions, Gaetz said publicly he would "no longer" voluntarily cooperate. He called the investigation "frivolous," adding, "Every investigation into me ends the same way: my exoneration." The report said that while Gaetz's obstruction of the investigation does not rise to a criminal violation it is inconsistent with the requirement that all members of Congress "act in a manner that reflects creditably upon the House." Justice Department didn't cooperate with the committee The committee began its review of Gaetz in April 2021 and deferred its work in response to a Justice Department request. It renewed its work shortly after Gaetz announced that the Justice Department had ended a sex trafficking investigation without filing any charges against him. The committee sought records from the Justice Department about the probe, but the agency refused, saying it doesn't disclose information about investigations that don't result in charges. The committee then subpoenaed the Justice Department, and after a back-and-forth between officials and the committee, the department handed over "publicly reported information about the testimony of a deceased individual," according to the report. "To date, DOJ has provided no meaningful evidence or information to the Committee or cited any lawful basis for its responses," the committee said. Many of the women who the committee spoke to had already given statements to the Justice Department and didn't want to "relive their experience," the committee said. "They were particularly concerned with providing additional testimony about a sitting congressman in light of DOJ's lack of action on their prior testimony," the report said. The Justice Department, however, never handed over the women's statements. The agency's lack of cooperation — along with its request that the committee pause its investigation — significantly delayed the committee's probe, lawmakers said.

Paves way for additional large indications markets TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based regenerative therapies, has announced significant findings from an expanded preclinical study of the potential of its portfolio drug, ExoPTEN, for repairing optic nerve damage. Conducted in collaboration with the Goldschleger Eye Institute at Sheba Medical Center, consistently ranked one of the top ten hospitals in the world 1 , the study builds on previously announced preliminary results 2 on June 28, 2024 and strengthens the suggestion of a promising treatment pathway for glaucoma, the leading cause of irreversible blindness globally 3 . The Optic Nerve Disorders treatment market is expected to grow from 5.54 (USD Billion) in 2023 to 11.5 (USD Billion) by 2032, at a compound annual growth rate (CAGR) of ~8.46% during the forecast period 4 . Researchers utilized a rodent model of optic nerve crush (ONC) to simulate the damage associated with conditions like glaucoma. After inducing injury, ExoPTEN was administrated via direct injection into the eyes. The study expanded on earlier findings which indicated that eyes treated with ExoPTEN regained nearly normal retinal activity, as evidenced by electrical tests. Expanded analyses of the study data showed clear recovery of signal transmission in treated eyes compared to untreated controls, which showed no significant response. Additionally, imaging results by optical coherence tomography (OCT) scans indicates and validates that in all of treated eyes (naïve exosome treatment or ExoPTEN treatment) a successful ONC procedure has been performed (Figure 1). The study also showed that ExoPTEN treatment significantly enhanced the survival of retinal ganglion cells - key neurons responsible for transmitting visual information to the brain. Detailed analysis of retinal flat-mounts confirmed this effect, with treated eyes exhibiting substantially higher counts of these cells compared to untreated or control-treated eyes (Figures 2A and 2B). Dr. Ifat Sher, the lead investigator from the Goldschleger Eye Institute, commented, "the results from this expanded study are extremely encouraging. ExoPTEN demonstrates potential as a treatment that restores functionality and offers neuroprotection. The study shows clear signal recovery, healthier optic nerve structures and preserved retinal ganglion cells. These results suggest that ExoPTEN could fundamentally change how we approach conditions like glaucoma and optic nerve trauma. Encouraged by these results, we are advancing to a larger study with more animals to validate and expand upon these findings.” Dr. Lior Shaltiel, CEO of NurExone, added, "these findings are an important step forward in our mission to develop groundbreaking therapies for regenerative medicine in several indications. ExoPTEN's ability to repair both the structure and function of the optic nerve highlights its transformative potential for addressing vision loss and improving tens of millions of patient lives.” About NurExone NurExone Biologic Inc. is a TSX Venture Exchange (" TSXV ”) and OTCQB listed pharmaceutical company that is developing a platform for biologically guided exosome-based therapies to be delivered, minimally-invasively, to patients who have suffered Central Nervous System injuries. The Company's first product, ExoPTEN for acute spinal cord injury, was proven to recover motor function in 75% of laboratory rats when administered intranasally. ExoPTEN has been granted Orphan Drug Designation by the United States Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). The NurExone platform technology is expected to offer novel solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. For additional information and a brief interview, please watch Who is NurExone? , visit www.nurexone.com or follow NurExone on LinkedIn , X (formerly Twitter) , Facebook or YouTube Dr. Lior Shaltiel Chief Executive Officer and Director Phone: +972-52-4803034 Email: [email protected] Oak Hill Financial Inc. 2 Bloor Street, Suite 2900 Toronto, Ontario M4W 3E2 Investor Relations - Canada Phone: +1-647-479-5803 Email: [email protected] Dr. Eva Reuter Investor Relations - Germany Phone: +49-69-1532-5857 Email: [email protected] Allele Capital Partners Investor Relations - US Phone: +1 978-857-5075 Email: [email protected] FORWARD-LOOKING STATEMENTS This press release contains certain "forward-looking statements” that reflect the Company's current expectations and projections about its future results. Wherever possible, words such as "may”, "will”, "should”, "could”, "expect”, "plan”, "intend”, "anticipate”, "believe”, "estimate”, "predict” or "potential” or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements relating to: the results of the Company's preclinical trials and its suggestion of a promising treatment pathway for glaucoma; the growth of the Optic Nerve Disorders treatment market; the Company expanding to further studies; the Company developing groundbreaking therapies for regenerative medicine in several indications; ExoPTEN having the potential to address vision loss and improve patient lives; and the NurExone platform technology offering novel solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof. In developing the forward-looking statements in this press release, we have applied several material assumptions, including : the a bility to carry out its pre-clinical trials and realize upon the stated benefits of the pre-clinical trials; the Company's ability to realize upon the stated potential for exosome-loaded drugs in regenerating or repairing damaged nerves; the Company's ability to maintain its ongoing commitment to using its ExoTherapy platform to advance the field of regenerative medicine; the Optic Nerve Disorders treatment market continuing to grow as stated; the Company expanding to further studies; the Company developing groundbreaking therapies for regenerative medicine in several indications; ExoPTEN addressing vision loss and improve patient lives; and the NurExone platform technology will offer novel solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These risks and uncertainties include, but are not limited to risks related to : the Company's early stage of development; lack of revenues to date; government regulation; market acceptance for its products; rapid technological change; dependence on key personnel; dependence on the Company's strategic partners; the fact that preclinical drug development is uncertain, and the drug product candidates of the Company may never advance to clinical trials; the fact that results of preclinical studies and early-stage clinical trials may not be predictive of the results of later stage clinical trials; the uncertain outcome, cost, and timing of product development activities, preclinical studies and clinical trials of the Company; the uncertain clinical development process, including the risk that clinical trials may not have an effective design or generate positive results; the potential inability to obtain or maintain regulatory approval of the drug product candidates of the Company; the introduction of competing drugs that are safer, more effective or less expensive than, or otherwise superior to, the drug product candidates of the Company; the initiation, conduct, and completion of preclinical studies and clinical trials may be delayed, adversely affected or impacted by unforeseen issues; the potential inability to obtain adequate financing; the potential inability to obtain or maintain intellectual property protection for the drug product candidates of the Company; risks that the Company's intellectual property and technology won't have the intended impact on the Company and/or its business; the Company's inability to carry out its pre-clinical trials and realize upon the stated benefits of the pre-clinical trials; the Company's inability to realize upon the stated potential for exosome-loaded drugs in regenerating or repairing damaged nerves; the Company's inability to maintain its ongoing commitment to using its ExoTherapy platform to advance the field of regenerative medicine; the Optic Nerve Disorders treatment market decreasing and/or plateauing ; the Company 's inability to expand into further studies; the NurExone platform technology not offering novel solutions to drug companies interested in minimally invasive targeted drug delivery for other indications ; and the risks discussed under the heading "Risk Factors” on pages 44 to 51 of the Company's Annual Information Form dated August 27 , 202 4 , a copy of which is available under the Company's SEDAR+ profile at www.sedarplus.ca . These factors should be considered carefully, and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, the Company cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law. Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. 1 https://www.afsmc.org/2024/02/sheba-medical-center-named-a-newsweek-worlds-best-hospital-for-the-6th-consecutive-year/ 2 https://www.globenewswire.com/news-release/2024/06/28/2906122/0/en/NurExone-s-ExoPTEN-Being-Studied-as-Glaucoma-Treatment-for-US-3-4-Billion-Market.html 3 https://www.mdpi.com/1424-8247/17/10/1261 4 https://www.marketresearchfuture.com/reports/optic-nerve-disorders-treatment-market-30051 A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5e682a60-3287-44b2-b7da-08ebed8fa807

Hutson scores 20 as Northern Iowa defeats Southern Illinois 78-67